Phase III randomized study of dacarbazine with or without allovectin-7 in patients with metastatic melanoma
Phase of Trial: Phase III
Latest Information Update: 06 Jun 2011
At a glance
- Drugs Dacarbazine; Velimogene aliplasmid
- Indications Malignant melanoma
- Focus Registrational; Therapeutic Use
- 06 Jun 2011 Results presented at 47th Annual Meeting of the American Society of Clinical Oncology (ASCO-2011).
- 24 Jul 2008 Status changed from in progress to completed as reported by ClinicalTrials.gov.
- 28 Sep 2005 New trial record.